Skip to main content

SHOEI YAKUHIN CO.,LTD.

昭栄薬品株式会社

Valuation

Fundamental ratios for the latest reported period.

Ticker: 3537
FY2025 · 2026-03-31
Gross margin8.0%
Operating margin1.9%
Net margin2.1%
Return on equity9.6%
Return on assets3.1%
Revenue growth (YoY)7.6%
EPS (basic)¥162.92
EPS growth (YoY)5.3%
Current ratio1.68x
Equity ratio32.4%
Book value / share¥2,749.72
Free cash flow101 M